A response to high-dose estrogen for tamoxifen, aromatase inhibitor and trastuzumab refractory HER2+ and ER+ advanced breast cancer

B. Nervi, A. Denes, Matthew J. Ellis

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Article numbere2
JournalBreast Cancer Online
Issue number1
StatePublished - Jan 2006
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Oncology(nursing)
  • Cancer Research

Cite this